Arcutis Biotherapeutics Inc (ARQT) — Cash Flow Quality Index
Latest as of December 2025:
1.51x
Arcutis Biotherapeutics Inc (ARQT) has a Cash Flow Quality Index of 1.51x as of December 2025. Operating cash flow of $26.18 Million exceeds net income of $17.39 Million, indicating high earnings quality where cash backs reported profits. Explore Arcutis Biotherapeutics Inc (ARQT) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
1.51x
Operating CF / Net Income
Operating Cash Flow
$26.18 Million
USD
Net Income
$17.39 Million
USD
Data as of
Dec 2025
Most recent filing
Annual Cash Flow Quality Index for Arcutis Biotherapeutics Inc (None–None)
Year-by-year earnings quality comparison for Arcutis Biotherapeutics Inc. For live market cap and the full company financial profile, see ARQT market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.